Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells

Bibliographic Data

ID23536641
AuthorsFeng Zhao (0000-0002-5568-8856), James Raine (corresponding author), SHENGLI PAN, Yan Gu (0000-0002-6103-5245), SHANYU GUO, QIANCHENG DAI, Yingyan Yu (0000-0002-3585-3252), Wei Zhang (0000-0002-5458-9581)
Year2015
Volume9
Issue1
Pages159-164
Publication date2015-01-01
Open AccessNo
TypeARTICLE
VenueOncology Letters (JOURNAL)
Journal identifiersISSN: 1792-1074 • E-ISSN: 1792-1082
PublisherSpandidos Publications (PUBLISHER • GR)
DOI10.3892/ol.2014.2633
PMID25435951
PMCIDPMC4246611
OpenAlexW25435951
LanguageEN
Citations received6
References cited26

Hypermethylated in cancer 1 (HIC-1) is a tumor suppressor gene, which is epigenetically silenced in breast cancer. It is known that the loss of HIC-1, caused by promoter hypermethylation, is associated with tumor aggression and poor survival in breast carcinoma. It has been shown that small activating RNA (saRNA) targeting promoter sequences may induce gene re-expression. In the current study, saRNA was used to restore HIC-1 expression, and the effects on colony formation, invasiveness and the cell cycle in breast cancer cells were explored. dsHIC1-2998, an saRNA, exhibited activating efficacy on MCF-7 and MDA-MB-231 cancer cell lines. A clonogenicity assay showed that evident colony inhibition was induced via saRNA-mediated re-expression of HIC-1 in the two cancer cell lines. Reactivation of HIC-1 significantly inhibited cell migration and invasion, resulting in G0/G1 cell cycle arrest in these cell lines. These findings suggest that HIC-1 may be a potential target in gene therapy for the treatment of breast cancer. saRNA may function as a therapeutic option for upregulating tumor suppressor genes in breast cancer.

Appalachia · Geography · Saddle · Appalachian Studies and Mathematics · Engineering · Forestry · Geology · Race, History, and American Society · Urban, Neighborhood, and Segregation Studies

Tools

Open DOISci-Hub